References
- Dodds W. J. Effect of warfarin on coagulation factor synthesis in isolated perfused livers. Fed. Proc. 1970; 29: 381, Abs.
- Ekelund H., Ganrot P. O., Unpublished
- Ernster L., Danielson L., Ljunggren M. DT-diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties. Biochim. biophys. Acta (Amst.) 1962; 58: 171
- Ganrot P. O., Niléhn J. E. Immunochemical determination of human prothrombin. Scand. J. clin. Lab. Invest. 1968; 21: 238
- Ganrot P. O., Niléhn J. E. Plasma prothrombin during treatment with dicumarol. II. Demonstration of an abnormal prothrombin fraction. Scand. J. clin. Lab. Invest. 1968; 22: 23
- Johnson B. C., Hill R. B., Alden R., Ranhotra G. A. Turnover time of prothrombin and of prothrombin messenger RNA and evidence for a ribosomal site of action of vitamin K in prothrombin synthesis. Life Sci. 1966; 5: 385
- Johnston M. F. M., Olson R. E. Prothrombin biosynthesis in a cell-free system. Fed. Proc. 1970; 29: 584, Abs.
- Martius C., Strufe R. Die Stellung des Phyllochinons (Vitamin K.) in der Atmungskette. Biochem. Z. 1954; 326: 24
- Olson J. P., Miller L. L., Troup S. B. Synthesis of clotting factors by the isolated perfused rat liver. J. clin. Invest. 1966; 45: 690
- Olson R. E., Kipfer R. K., Li R. F. Evidence for a ribosomal site of action for vitamin K. Clin. Res. 1969; 17: 465
- Owren P. A., Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 1951; 3: 201
- Pereira M. A. Inhibition of glucosamine-14C-incorporation in vivo and in vitro into prothrombin. Fed. Proc. 1970; 29: 382, Abs.
- Ranhotra G. S., Johnson B. C. Vitamin K and prothrombin formation. Life Sci. 1970; 9: 79, (Part II)
- Suttie J. W. Control of prothrombin and factor VII biosynthesis by vitamin K. Arch. Biochem. 1967; 118: 166